| Literature DB >> 33299422 |
Abstract
BACKGROUND: On placental histology, placenta creta (PC) ranges from clinical placenta percreta through placenta increta and accreta (clinical and occult) to myometrial fibers with intervening decidua. This retrospective study aimed to investigate the clinicopathologic correlations of these lesions.Entities:
Year: 2020 PMID: 33299422 PMCID: PMC7707967 DOI: 10.1155/2020/4230451
Source DB: PubMed Journal: Obstet Gynecol Int ISSN: 1687-9597
Figure 1Placenta creta spectrum (haematoxylin and eosin, original objective magnifications are given in parentheses). (a) Placenta increta: myometrial fibers are intermingled with chorionic villi (20x). (b) Placenta percreta: placental tissue is separated from the subperitoneal fat only by fibrous tissue (10x). (c) Symptomatic placenta accreta: myometrial tissue in direct contact with the intervillous space (10x). (d) Occult placenta accreta: extravillous trophoblasts with underlying myometrial fibers in direct contact with the intervillous space (10x). (e) Occult placenta accreta: Rohr fibrinoid with an underlying mix of myometrial fibers and extravillous trophoblast (10x). (f) Basal plate myometrial fibers: Rohr fibrinoid with underlying decidua, Nitabush fibrinoid, and myometrial fibers (40x). (g) Myometrial fibers in a shaved section from a margin of disruption of the maternal floor (20x). (h) Placental membranes with adjacent myometrial fibers (chorion leave accreta) (10x).
Clinical phenotypes.
| Group 1: placenta creta | Group 2: no placenta creta |
|
| |
|---|---|---|---|---|
| Number of cases | 169 | 1661 | ||
| Gestational hypertension | 19 (11.2%) | 72 (4.3%) | 15.5 | 0.001 |
| Preeclampsia | 20 (11.8%) | 43 (2.6%) | 39.4 | 0.001 |
| Chronic hypertension | 5 (3.0%) | 47 (2.8%) | ||
| Gestational age (weeks, average ± standard deviation) | 32.8 ± 6.6 | 32.3 ± 7.4 | ||
| Maternal diabetes mellitus | 9 (5.3%) | 114 (6.9%) | ||
| Oligohydramnios | 18 (10.6%) | 153 (9.2%) | ||
| Polyhydramnios | 16 (9.5%) | 93 (5.6%) | ||
| Antepartum hemorrhage | 30 (17.7%) | 193 (11.6%) | 5.4 | 0.020 |
| Abnormal fetal heart rate tracinga | 26 (15.4%) | 331 (19.9%) | ||
| Abnormal umbilical artery Doppler | 12 (7.1%) | 242 (14.6%) | ||
| Induction of labor | 23 (13.6%) | 309 (18.6%) | ||
| Placenta previa | 3 (1.8%) | 11 (0.7%) | ||
| Cesarean section | 95 (56.2%) | 750 (45.1%) | 7.6 | 0.060 |
| Postcesarean hysterectomy | 4 (1.7%) | 1 (0.7%) | ||
| Multiple pregnancy | 16 (9.5%) | 127 (7.6%) | ||
| Neonatal mortality | 21 (12.4%) | 212 (12.8%) | ||
| Nonmacerated stillbirth | 9 (5.3%) | 79 (4.6%) | ||
| Macerated stillbirth | 22 (13.0%) | 275 (16.6%) | ||
| Fetal growth restrictionb | 34 (20.1%) | 301 (18.1%) | ||
| Umbilical cord compromisec | 16 (9.5%) | 122 (7.3%) | ||
| Congenital malformations | 39 (23.1%) | 335 (20.1%) | ||
| Abnormal 3rd stage of labor (prolonged, hemorrhage) | 32 (18.9%) | 107 (6.4%) | 34.1 | 0.001′ |
| Manual extraction of placenta (not during hysterectomy) | 20 (11.8%) | 19 (1.1%) | 84.0 | 0.001 |
aAbnormal nonstress test and/or abnormal contraction stress test and/or abnormal intrapartum cardiotocography (prolonged bradycardia and/or prolonged tachycardia and or decrease of fetal heart rate variability and/or late decelerations), bbirth weight <10 centile, cvariable decelerations, encirclement, true knot, or prolaps.
Placental phenotypes.
| Group 1: placenta creta | Group 2: no placenta creta | Chi-square or |
| |
|---|---|---|---|---|
| Number of cases | 169 | 1661 | ||
| Placental weight (grams ±standard deviation) | 372.8 ± 183.4 | 361.2 ± 198.1 | ||
|
| ||||
| Chronic villitis of unknown etiology | 16 (9.5%) | 216 (13.0%) | ||
| Plasma cell deciduitis | 9 (5.3%) | 81 (4.9%) | ||
|
| ||||
|
| ||||
| Meconium (histological) | 65 (38.5%) | 710 (42.7) | ||
| Villous infarction (>5% of placental parenchyma) | 24 (14.2%) | 148 (8.9%) | 5.0 | 0.025 |
|
| ||||
| Erythroblastosis of fetal blood | 32 (18.9%) | 265 (15.9%) | ||
| Hyaline necrosis, including atherosis of spiral arterioles | 11 (6.5%) | 81 (4.9%) | ||
| Patterns of chronic hypoxic placental injury | 49 (29.0%) | 334 (20.1%) | 7.3 | 0.007 |
| Preuterine | 9 (5.3%) | 84 (5.1%) | ||
| Uterine | 25 (14.8%) | 159 (9.6%) | 4.6 | 0.032 |
| Postuterine | 15 (8.9%) | 91 (5.5%) | ||
| Retroplacental hematoma | 9 (5.3%) | 108 (6.5%) | ||
| Intervillous thrombus | 37 (21.9%) | 294 (17.7%) | ||
|
| ||||
| Membrane chorionic microcysts | 23 (13.6%) | 203 (12.2%) | ||
| Chorionic disc extravillous trophoblast microcysts | 37 (21.9%) | 264 (15.9%) | 4.0 | 0.045 |
| Maternal floor multinucleate trophoblast giant cells | 47 (27.8%) | 352 (21.2%) | 3.9 | 0.047 |
| Excessive extravillous trophoblasts in chorionic disc | 41 (24.3%) | 288 (17.3%) | 5.0 | 0.026 |
|
| ||||
| Segmental fetal vascular malperfusion | 47 (27.4%) | 330 (19.9%) | 5.9 | 0.015 |
| Segmental stromal vascular karyorrhexis | 14 (8.3%) | 100 (6.0%) | ||
| Segmental villous mineralization | 12 (7.1%) | 146 (8.8%) | ||
| Fetal vascular ectasia | 45 (26.2%) | 253 (15.2%) | 14.6 | 0.001 |
| Stem vessel obliteration | 16 (9.5%) | 135 (8.1%) | ||
| Intramural fibrin deposition | 7 (4.1%) | 124 (7.5%) | ||
|
| ||||
| Massive perivillous fibrin deposition (>30% of placental parenchyma) | 16 (9.5%) | 88 (5.3%) | 5.0 | 0.026 |
| Choriodecidual hemosiderosis | 10 (5.9%) | 115 (6.9%) | ||
| Villous edema | 9 (5.3%) | 141 (8.5%) | ||
| Marginal insertion of umbilical cord | 18 (10.6%) | 112 (6.7%) | ||
| Velamentous insertion of umbilical cord | 7 (4.1%) | 52 (3.1%) | ||
| Other umbilical cord abnormalities | 30 (17.7%) | 278 (16.7%) | ||
Figure 2Lesions of shallow placental implantation (a–c), hypoxic lesions (d–f), and fetal vascular malperfusion lesions (g, h) statistically significant more common in group 1 (original objective magnifications are given in parentheses). (a) Confluent cell islands (excessive extravillous trophoblasts) (haematoxylin eosin, 4x). (b) Chorionic microcysts (haematoxylin eosin, 4x). (c) A cluster of multinucleate trophoblasts and hypertrophic decidual arteriopathy in maternal floor (haematoxylin eosin, 40x). (d) Uterine chronic hypoxic pattern at 34 weeks gestation (haematoxylin eosin, 10x). (e) Villous infarction (haematoxylin eosin, 10x). (f) Massive perivillous fibrinoid deposition (dissecting microscopy). (g) Incipient segmental villous hypovascularity (E cadherin (brown)/CD34 (red) immunostain, 10x). (h) Fetal stem vascular ectasia, global fetal vascular malperfusion (haematoxylin and eosin, 4x).